The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis

Acta Psychiatrica Scandinavica

Volumn 112, Issue 2, 2005, Pages 141-148

  Lambert, Martin ^a,d   Conus, P ^b   Lubman, D I ^c   Wade, D ^c   Yuen, H ^c   Moritz, S ^a   Naber, D ^a   McGorry, P D ^c   Schimmelmann, B G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

First episode psychosis; Schizophrenia; Substance use disorder; Symptomatic remission

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DEPENDENCE; FEMALE; FIRST EPISODE PSYCHOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; AUSTRALIA; BENZODIAZEPINES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PREVALENCE; PSYCHOSES, SUBSTANCE-INDUCED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISPERIDONE; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 22344447728     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00554.x     Document Type: Article

References (35)

1. REGIER DA, FARMER ME, RAE DS et al. Co-morbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
2. SEVY S, ROBINSON DG, HOLLOWAY S et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001;104:367-374.
3. KAVANAGH DJ, WAGHORN G, JENNER L et al. Demographic and clinical correlates of co-morbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 2004;66:115-124.
4. WADE D, HARRIGAN S, WHELAN G, BURGESS P, MCGORRY P. The impact of substance use disorders on clinical outcome in first-episode psychosis. Schizophr Res 2004;67 (Suppl. 1):B172.
5. MUESER KT, DRAKE RE, ACKERSON TH, ALTERMAN AI, MILES KM, NOORDSY DL. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia. J Abnorm Psychol 1997;106:473-477.
6. PATKAR AA, ALEXANDER RC, LUNDY A, CERTA KM. Changing patterns of illicit substance use among schizophrenic patients: 1984-1996. Am J Addict 1999;8:65-71.
7. BLANCHARD JJ, BROWN SA, HORAN WP, SHERWOOD AR. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000;20:207-234.
8. CANTOR-GRAAE E, NORDSTROM LG, MCNEIL TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001;48:69-82.
9. DUKE PJ, PANTELIS C, MCPHILLIPS MA, BARNES TR. Co-morbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 2001;179:509-513.
10. SALYERS MP, MUESER KT. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 2001;48:109-123.
11. NEGRETE JC. Clinical aspects of substance abuse in persons with schizophrenia. Can J Psychiatry 2003;48:14-21.
12. ARNDT S, TYRRELL G, FLAUM M, ANDREASEN NC. Co-morbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychol Med 1992;22:379-388.
13. ZISOOK S, HEATON R, MORANVILLE J, KUCK J, JERNIGAN T, BRAFF D. Past substance abuse and clinical course of schizophrenia. Am J Psychiatry 1992;149:552-553.
14. ROSENTHAL RN, HELLERSTEIN DJ, MINER CR. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Compr Psychiatry 1994;35:91-98.
15. ADDINGTON J, ADDINGTON D. Effect of substance misuse in early psychosis. Br J Psychiatry Suppl 1998;17:134-136.
16. DEQUARDO JR, CARPENTER CF, TANDON R. Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 1994;28:267-575.
17. RABINOWITZ J, BROMET EJ, LAVELLE J, CARLSON G, KOVASZNAY B, SCHWARTZ JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 1998;28:1411-1419.
18. OWEN RR, FISCHER EP, BOOTH BM, CUFFEL BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996;47:853-858.
19. SWOFFORD CD, KASCKOW JW, SCHELLER-GILKEY G, INDERBITZIN LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145-151.
20. LINSZEN DH, DINGEMANS PM, LENIOR ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-279.
21. LAMBERT M, HAASEN C, MAß R et al. Relationship of substance abuse disorders and suicidality in paranoid schizophrenic patients. Nervenheilkunde 2000;19:69-75.
22. KAMALI M, KELLY L, GERVIN M, BROWNE S, LARKIN C, O'CALLAGHAN E. The prevalence of co-morbid substance misuse and its influence on suicidal ideation among inpatients with schizophrenia. Acta Psychiatr Scand 2000; 101:452-456.
23. SORBARA F, LIRAUD F, ASSENS F, ABALAN F, VERDOUX H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry 2003; 18:133-136.
24. MCGORRY PD, EDWARDS J, MIHALOPOULOS C, HARRIGAN SM, JACKSON HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-326.
25. EDWARDS J, MCGORRY PD. Implementing early intervention in psychosis. A guide to establishing early psychosis services. London: Martin Dunitz Ltd, 2002.
26. American Psychiatric Association Diagnostic Criteria from DSM-IV. Washington: American Psychiatric Press, 1994.
27. MCGORRY PD, COPOLOV DL, SINGH BS. Royal park multidiagnostic instrument for psychosis. Part I. Rationale and review. Schizophr Bull 1990a;16:501-515.
28. MCGORRY PD, SINGH BS, COPOLOV DL, KAPLAN I, DOSSETOR CR, VAN RIEL RJ. Royal park multidiagnostic instrument for psychosis. Part II. Development, reliability, and validity. Schizophr Bull 1990b;16:517-536.
29. GUY W. ECDEU assessment manual for psychopharmacology, revised. DHEW Pub. No. (ADM) 76-338. Rockville: National Institute of Mental Health, 1976.
30. KANE JM, LEUCHT S, CARPENTER D. Expert consensus guidelines for optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry 2003;64 (Suppl.12).
31. VAN MASTRIGT S, ADDINGTON J, ADDINGTON D. Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 2004;39:69-72.
32. GOSSOP M, MARSDEN J, STEWART D et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998;173: 166-171.
33. LUBMAN DI, SUNDRAM S. Substance misuse in patients with schizophrenia: a primary care guide. Med J Aust 2003;178: 71-75.
34. BAKER A, LEWIN T, REICHLER H et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatr Scand 2002;106:233-240.
35. KAVANAGH DJ, YOUNG R, WHITE A et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev 2004;23:151-155.